Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 2509 to 2513 of 2513 entries
Sorted by: Best Match Show Resources per page
Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells [Retraction].

International journal of clinical and experimental pathology

[No authors listed]
PMID: 33284881
Int J Clin Exp Pathol. 2020 Nov 01;13(11):2916. eCollection 2020.

[This retracts the article on p. 9621 in vol. 10, PMID: 31966840.].

Cite
Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells [Retraction]. Int J Clin Exp Pathol. 2020;13(11):2916
(2020). Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells [Retraction]. International journal of clinical and experimental pathology, 13(11), 2916.
"Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells [Retraction]." International journal of clinical and experimental pathology vol. 13,11 (2020): 2916.
Role of macrophage migration inhibitory factor in mesenchymal epithelial transition of cervical carcinoma cells [Retraction]. Int J Clin Exp Pathol. 2020 Nov 01;13(11):2916. eCollection 2020. PMID: 33284881; PMCID: PMC7716129.
Copy Download .nbib Format: NLM
Collision tumor of carcinoma and lymphoma in the cecum: case report and review of literature.

International journal of clinical and experimental pathology

Bao L, Feng X, Wang T, Xing F.
PMID: 33284884
Int J Clin Exp Pathol. 2020 Nov 01;13(11):2907-2915. eCollection 2020.

Collision tumors that occur in the gastrointestinal tract, especially the intestine, are rare, and collisions of carcinoma and lymphoma are even more rare. We report a case of collision tumor with adenocarcinoma and non-Hodgkin's diffuse large B-cell lymphoma in...

Cite
Bao L, Feng X, Wang T, et al. Collision tumor of carcinoma and lymphoma in the cecum: case report and review of literature. Int J Clin Exp Pathol. 2020;13(11):2907-2915
Bao, L., Feng, X., Wang, T., & Xing, F. (2020). Collision tumor of carcinoma and lymphoma in the cecum: case report and review of literature. International journal of clinical and experimental pathology, 13(11), 2907-2915.
Bao, Lei, et al. "Collision tumor of carcinoma and lymphoma in the cecum: case report and review of literature." International journal of clinical and experimental pathology vol. 13,11 (2020): 2907-2915.
Bao L, Feng X, Wang T, Xing F. Collision tumor of carcinoma and lymphoma in the cecum: case report and review of literature. Int J Clin Exp Pathol. 2020 Nov 01;13(11):2907-2915. eCollection 2020. PMID: 33284884; PMCID: PMC7716123.
Copy Download .nbib Format: NLM
Microcystic urothelial carcinoma: a case report.

International journal of clinical and experimental pathology

Liu M, Liu S, Bao L, Chen W, Yang P, Zhou H.
PMID: 33284896
Int J Clin Exp Pathol. 2020 Nov 01;13(11):2778-2783. eCollection 2020.

Microcystic urothelial carcinoma (MUC) is a rare variant of urothelial carcinoma that is highly aggressive with poor prognosis. Due to the scarcity of cases, its histologic morphology and immunohistochemical characteristics are still not clear. This paper reports a 71-year...

Cite
Liu M, Liu S, Bao L, et al. Microcystic urothelial carcinoma: a case report. Int J Clin Exp Pathol. 2020;13(11):2778-2783
Liu, M., Liu, S., Bao, L., Chen, W., Yang, P., & Zhou, H. (2020). Microcystic urothelial carcinoma: a case report. International journal of clinical and experimental pathology, 13(11), 2778-2783.
Liu, Mengyao, et al. "Microcystic urothelial carcinoma: a case report." International journal of clinical and experimental pathology vol. 13,11 (2020): 2778-2783.
Liu M, Liu S, Bao L, Chen W, Yang P, Zhou H. Microcystic urothelial carcinoma: a case report. Int J Clin Exp Pathol. 2020 Nov 01;13(11):2778-2783. eCollection 2020. PMID: 33284896; PMCID: PMC7716137.
Copy Download .nbib Format: NLM
Diagnostic value of beclin-1 and mTOR in ovarian cancer.

International journal of clinical and experimental pathology

Lu H, Hu H, Li S.
PMID: 33564356
Int J Clin Exp Pathol. 2021 Feb 01;14(2):238-246. eCollection 2021.

This study described the expression of beclin-1 and mTOR proteins in 86 ovarian tumor tissue samples (n=25 benign ovarian tumor tissues; n=16 borderline ovarian tumor tissues; n=45 malignant epithelial ovarian tumor tissues) and 20 normal ovarian tissue samples and...

Cite
Lu H, Hu H, Li S. Diagnostic value of beclin-1 and mTOR in ovarian cancer. Int J Clin Exp Pathol. 2021;14(2):238-246
Lu, H., Hu, H., & Li, S. (2021). Diagnostic value of beclin-1 and mTOR in ovarian cancer. International journal of clinical and experimental pathology, 14(2), 238-246.
Lu, Huixia, et al. "Diagnostic value of beclin-1 and mTOR in ovarian cancer." International journal of clinical and experimental pathology vol. 14,2 (2021): 238-246.
Lu H, Hu H, Li S. Diagnostic value of beclin-1 and mTOR in ovarian cancer. Int J Clin Exp Pathol. 2021 Feb 01;14(2):238-246. eCollection 2021. PMID: 33564356; PMCID: PMC7868785.
Copy Download .nbib Format: NLM
Mechanistic and Translational Advances Using iPSC-Derived Blood Cells.

Journal of Experimental Pathology

Thom CS, Chou ST, French DL.
PMID: 33768218
J Exp Pathol (Wilmington). 2020;1(2):36-44. doi: 10.33696/pathology.1.010.

Human induced pluripotent stem cell (iPSC)-based model systems can be used to produce blood cells for the study of both hematologic and non-hematologic disorders. This commentary discusses recent advances that have utilized iPSC-derived red blood cells, megakaryocytes, myeloid cells,...

Cite
Thom CS, Chou ST, French DL. Mechanistic and Translational Advances Using iPSC-Derived Blood Cells. J Exp Pathol (Wilmington). 2020;1(2):36-44doi: 10.33696/pathology.1.010.
Thom, C. S., Chou, S. T., & French, D. L. (2020). Mechanistic and Translational Advances Using iPSC-Derived Blood Cells. Journal of Experimental Pathology, 1(2), 36-44. https://doi.org/10.33696/pathology.1.010
Thom, Christopher S, et al. "Mechanistic and Translational Advances Using iPSC-Derived Blood Cells." Journal of Experimental Pathology vol. 1,2 (2020): 36-44. doi: https://doi.org/10.33696/pathology.1.010
Thom CS, Chou ST, French DL. Mechanistic and Translational Advances Using iPSC-Derived Blood Cells. J Exp Pathol (Wilmington). 2020;1(2):36-44. doi: 10.33696/pathology.1.010. PMID: 33768218; PMCID: PMC7990314.
Copy Download .nbib Format: NLM
Showing 2509 to 2513 of 2513 entries